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A B S T R A C T
The availability of human pluripotent stem cells (hPSCs) and progress in genome engineering technology have
altered the way we approach scientiﬁc research and drug development screens. Unfortunately, the procedures
for genome editing of hPSCs often subject cells to harsh conditions that compromise viability: a major problem
that is compounded by the innate challenge of single-cell culture. Here we describe a generally applicable
workﬂow that supports single-cell cloning and expansion of hPSCs after genome editing and single-cell sorting.
Stem-Flex and RevitaCell supplement, in combination with Geltrex or Vitronectin (VN), promote reliable single-
cell growth in a feeder-free and deﬁned environment. Characterization of ﬁnal genome-edited clones reveals that
pluripotency and normal karyotype are retained following this single-cell culture protocol. This time-eﬃcient
and simpliﬁed culture method paves the way for high-throughput hPSC culture and will be valuable for both
basic research and clinical applications.
1. Introduction
Human pluripotent stem cells, including induced pluripotent stem
cells (hiPSCs) and human embryonic stem cells (hESCs), hold great
promise for cell research and clinical applications (Kiskinis and Eggan,
2010; Park et al., 2008; Saha and Jaenisch, 2009). Recent advances in
genome engineering and speciﬁcally the clustered regularly interspaced
short palindromic repeat (CRISPR) and CRISPR associated 9 (Cas9)
endonuclease system makes the human genome more amenable than
ever to genetic research. By combining these two technologies, scien-
tists are now able to correct disease-associated mutations in patient-
derived iPSCs enabling researchers to avoid confounding, complex ge-
netic background eﬀects via the creation of isogeneic control iPSCs.
Alternatively, genome engineering allows the introduction of disease-
associated mutations into ‘normal’ iPSC lines such that genetic dis-
orders can be modeled without the need to obtain patient cells har-
boring the speciﬁc disease-causing mutations. Additionally, genome
engineering can be used to modify endogenous loci such that en-
dogenous proteins can be tagged with ﬂuorescent or other protein do-
mains, creating reporter lines that can be used for high throughput
screening of small molecule libraries to search for therapeutic
compounds or for cell tracing experiments (Doudna and Charpentier,
2014; Hsu et al., 2014).
Traditional hPSC expansion requires feeder cells and serum-con-
taining media to maintain the “stemness” of the hPSCs (Stojkovic et al.,
2004). Recently, the need for pharmacological and medical applications
has driven the development of fully deﬁned and xeno-free media for
hPSC culture with improved surface matrices to achieve feeder-free
culture conditions (Braam et al., 2008; Chen et al., 2011; Ludwig et al.,
2006a, b; Rodin et al., 2014). Routine expansion of hPSCs involves
passaging of cells as small aggregates or clumps to avoid unwanted
selective pressure on cell populations and cell death associated with
single-cell dissociation. It is generally not recommended to passage
hPSCs as single cells as it can lead to genetic aberrations in the culture
(Buzzard et al., 2004). However, for the practice of transfection or
identifying singe-cell derived genome edited clones, it is important to
dissociate cells in a single-cell manner. Although recent improved
chemically deﬁned media have shown excellent performance for rou-
tine hPSC culture, poor cell viability and clonogenicity of cultured
single hPSCs remains as a major bottleneck after single-cell passaging.
Diﬀerent approaches including extracellular matrices (Higuchi et al.,
2015; Rodin et al., 2014), protein inhibitors (Valamehr et al., 2012;
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Watanabe et al., 2007), irradiated mouse embryonic ﬁbroblasts (MEFs)
(Yang et al., 2013) and human serum-derive protein (Pijuan-Galito
et al., 2016) have shown improved survival of single-cell derived hPSC
clones. However, these methods have not been widely implemented,
being either too expensive, lacking commercial availability, the need
for MEFs or poor reproducibility. Such systems are particular laborious
and ineﬃcient for genetically modifying hPSCs with CRISPR-Cas9;
especially with low editing rates observed for knock-in modiﬁcations.
Thus, there is a great need to develop a simpliﬁed and robust protocol
that can support high-throughput and reliable single-cell derived clonal
growth of stable hPSCs.
In the present study, we demonstrate that Stem-Flex media with
RevitaCell supplement is ideal for single-cell culture of hPSCs. We also
perform an unbiased comparison among diﬀerent commercially avail-
able feeder-free culture systems and supplements on their performance
with single-cell cloning and expansion of cloned hPSCs. Herein, we
describe a simpliﬁed and time-eﬃcient cell culture system for single-
cell cloning, supporting expansion of clones while undergoing genome
editing and maintaining pluripotency.
2. Material and methods
Several hPSC lines were used in this study including H9 and H1
hESCs (WiCell), WTC11 (Coriell institute), BJFF.6 and other iPSCs
(GEiC or collaborators). hPSCs were maintained on Matrigel (Corning)
coated plate in E8-Flex/Stem-Flex medium (ThermoFisher) unless
otherwise noted. FACS was conducted on a MoFlo cell sorter (Beckman
Coulter). hPSCs karyotype (G-banding) analysis was performed by Cell
Line Genetics and Cytogenetics core at Washington University in St.
Louis. Pluripotency of hPSCs were characterized for SSEA4, OCT4,
SOX2, and TRA-1-61. hPSCs diﬀerentiation was assessed for AFP, SMA
and TUJ1. Immunoﬂuorescent images of the stained cells were captured
using the Nikon ﬂuorescence microscope and CCD camera. Statistical
analysis was performed using Prism GraphPad 6.0. A p value of< 0.05
was considered statistically signiﬁcant. Comprehensive information on
the experimental procedures is described in the Supplemental
Information.
3. Results
3.1. TrypLE-Select and ROCK inhibitor support cell survival and expansion
after single-cell passage
Both enzymatic and enzyme-free reagents have been commonly
used for routine hPSC passaging. Many dissociation reagents have been
designed to gently separate multicellular colonies from the substrate
into small cell aggregates, and single-cell suspension can be further
achieved by adjusting the dissociation conditions (Fig. 1A). To de-
termine which dissociation reagents can be used to support single-cell
culture, single cells were dissociated and maintained in E8-Flex deﬁned
media.Three diﬀerent hPSC lines cells were plated at 10,000 cells/well
in 6-well plates (Fig. S1A). After 7 days in culture, wells with surviving
cells were counted. While non-enzymatic cell dissociation reagent is
reported to be gentler on cells (Beers et al., 2012), it showed poor
support on cell survival following single-cell passaging for three dif-
ferent hPSC lines (Fig. 1B). In contrast, a recombinant protease based
TrypLE-Select (TrypLE-S) reagent supported nearly 3-fold higher cell
survival in single-cell culture conditions for the BJFF.6 hPSC line. In
addition, 0.75× TrypLE-S showed the best survival rate following
single-cell dissociation compared to other passaging reagents for the
BJFF.6 hPSC line. Similar results were obtained using crystal violet
staining (Fig. 1C and Fig. S1B). Therefore, 0.75× TrypLE-S was used for
single cell dissociation for our subsequent studies.
Small molecular inhibitors of speciﬁc signaling pathways have been
used in iPSC generation and maintenance (Valamehr et al., 2012;
Watanabe et al., 2007). To determine whether small molecule
inhibitors further support hPSC single-cell survival and growth; BJFF.6
cells were dissociated into single cells and then seeded in Matrigel-
coated plates with E8-Flex plus Y-27632 (traditional ROCK inhibitor:
ROCKi), RevitaCell (supplement containing a proprietary ROCKi) or
SMC4 (small molecule cocktail of 4 inhibitors, consisting SB431542
(TGF-β), PD0325901 (MEK), CHIR99021 (GSK) and Thiazovivin
(ROCK)) supplementation. Viability of cells was evaluated at day 4, 5
and 6 after single-cell dissociation. While TrypLE-S can support cell
survival of single cell passage, the addition of ROCK inhibitors en-
hanced cell viability as previously reported (Watanabe et al., 2007)
(Fig. 1D). Cells seeded in Y-27632 or RevitaCell supplemented medium
(E8-Flex) exhibited similar viability levels, whereas seeding into SMC4
showed poor survival, in contrast to the previous studies with con-
ventional or mTeSR1 medium (Valamehr et al., 2012; Yang et al.,
2013). Moreover, the cells with SMC4 supplement showed ﬂat and
scattered morphology as compared to ROCKi containing supplements
(Fig. S1C). While Y-27632 and RevitaCell showed similar viability le-
vels in BJFF.6 cells, higher cell survival was observed in H9 and WTC
cells using RevitaCell compared to Y-27632 (Fig. S1D). Together, these
ﬁndings establish 0.75× TrypLE-S support cell survival in single-cell
dissociation culture and the addition of ROCK inhibitors enhanced
adaption eﬃciency of single-cell growth.
3.2. RevitaCell and Geltrex/VN support single-cell cloning after sorting by
ﬂow cytometry
While both ROCKi-containing additives, Y-27632 and RevitaCell,
can enhance single-cell viability after passaging, RevitaCell has been
shown to be a more selective ROCK inhibitor (SCIENTIFIC, 2015). To
test whether either supplement could support single-cell growth after
ﬂow cytometry based cell sorting, various cell densities of BJFF.6 cells
were sorted into Matrigel coated 96-well plates and the cloning eﬃ-
ciency was assessed at day 8. Interestingly, the addition of Y-27632 did
not support single-cell growth whereas RevitaCell was able to support
single cell growth with 12% and 17% clonability in 1 cell/well and 3
cells/well, respectively (Fig. 2A). RevitaCell was therefore used for
single-cell sorting in our subsequent studies. While various times of
ROCKi pre-treatment of hPSCs have been shown to improve single-cell
clonal growth (Pijuan-Galito et al., 2016; Watanabe et al., 2007), we
found that at least 1 h pre-treatment with ROCKi is suﬃcient for single-
cell splitting and sorting procedure (data not shown).
Many extracellular matrices have been developed for feeder-free
culture of hPSCs (Fig. 2B). In addition, some xeno-free and chemically
deﬁned substrates such as VN and COAT-1 can be applied to support
xeno-free culture conditions for clinical applications. To determine
whether diﬀerent coating matrices could support clonal growth of
single hPSCs, four diﬀerent hPSC lines were pre-treated with RevitaCell
and single cells were sorted into plates coated with diﬀerent coating
reagents. Increased clonal eﬃciency was observed in COAT-1, Geltrex,
VN and Laminin-521 groups as compared to Matrigel across diﬀerent
hPSC lines with Geltrex and VN groups showing up to 40% clonal ex-
pansion (Fig. 2C). Similar to BJFF.6, both H1 and H9 hESCs showed
coating reagent-dependent eﬀect on clonal eﬃciency while WTC11 was
less sensitive to diﬀerent matrices (Fig. 2C). While similar clonability
was observed in Laminin-521 across diﬀerent hPSC lines, we continued
on with Geltrex and VN since there was no dramatic increase in clon-
ability and the cost was prohibitive.
A number of diﬀerent culture conditions or additives have been
shown to enhance hPSC clonal growth, such as low physiological
oxygen condition (Forsyth et al., 2006), the addition of ﬁbronectin
(Valamehr et al., 2012) and the usage of conditioned medium (Yumlu
et al., 2017). Additionally, keeping cells chilled on ice should slow
down cellular activities and could mitigate the stress following single-
cell dissociation or ﬂow cytometry-based sorting. To test the eﬀects of
these culture conditions on single-cell survival after ﬂow cytometry
based sorting, Three diﬀerent hPSC lines were sorted into Geltrex-
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coated plates with deﬁned culture media (E8-Flex: RevitaCell). Keeping
cells chilled during the cell dissociation and ﬂow sorting process did not
increase clonal survival of BJFF.6 or H9 cells, but a decrease in clon-
ability was observed in WTC11 cells (Fig. 2D). While a subtle increase
(5% increase) in clonal eﬃciency was observed using 50% conditioned
medium in BJFF.6 cells, there was no signiﬁcant clonal survival dif-
ference between controls and ﬁbronectin-supplemented or conditioned
medium (Fig. 2D). However, in contrast to normoxia (20% O2), phy-
siological oxygen (2.5% O2) reduced hPSC clonal growth in BJFF.6,
WTC11, and H9 lines. (Fig. 2D). Together, these ﬁndings demonstrate
that the combination of RevitaCell with Geltrex or VN signiﬁcantly
increased clonal eﬃciency following our single cell sorting workﬂow.
3.3. Easy adaption of single-cell cloning workﬂow
The advantages of the RevitaCell and Geltrex/VN were combined to
develop a high-throughput method for obtaining clonally derived
hPSCs following a genome-engineering workﬂow (Fig. 3A). Colony
formation could be seen as early as 3 days post-sorting, and colonies
could be harvested for the downstream analysis as early as 11 or
12 days post-sorting (Movie S1). To test whether our single-cell cloning
workﬂow can support robust clonal eﬃciency using diﬀerent culture
systems, we compared the workﬂow using E8-Flex with four other
media. RevitaCell supplement was used in E8-Flex, Stem-Flex and DEF-
CS culture systems. For mTeSR1 and TeSR-E8, CloneR was used per
manufacturer's instructions. While the addition of ROCKi was not re-
commended by the manufacturer for the DEF-CS culture system, we
found that clonal eﬃciency was almost 4-fold higher when RevitaCell
was added (Fig. S2A). RevitaCell was therefore used in DEF-CS culture
medium in our subsequent comparison for single-cell clonal eﬃciency.
We assessed the clonal eﬃciency for 4 diﬀerent hPSC lines. Cloning
rates up to 55% were achieved with Stem-Flex:Geltrex, and the cloning
eﬃciency was consistently higher using E8-Flex or Stem-Flex (Fig. 3B).
To further compare the clonal eﬃciency of diﬀerent culture sys-
tems, three iPS cell lines with low clonability (< 25%) using E8-
Flex:Geltrex were chosen. The Stem-Flex:Geltrex culture system showed
better overall clonal eﬃciency (Fig. 3C). It should be noted that the
dramatic diﬀerence on clonal eﬃciency was observed in F10336.3 and
HT112F when using E8-Flex, mTeSR1, TeSR-E8 or DEF-CS systems,
underscoring the importance of culture medium on single cell cloning.
Together, these data demonstrate that single-cell clones can be isolated
using our single-cell workﬂow, albeit at diﬀerent eﬃciencies, in all
tested culture systems, and that consistent and high clonal eﬃciency
can be achieved in the Stem-Flex culture system.
3.4. Single cell cloning protocol does not increase genetic abnormalities
Over 100 genome engineering projects have been completed using a
variety of hPSC lines in our center (Table S1 and S2). Clonal eﬃciency
for each project was conducted at day 11–12 following single cell
sorting and projects were grouped by basal culture medium (E8-Flex
and Stem-Flex) and type of modiﬁcations (Fig. 4A). Karyotype analysis
was routinely performed in selected ﬁnal edited clones to assess the
chromosomal integrity. A representative karyogram of a selected clone
demonstrates that hPSCs retained a normal karyotype (Fig. 4B).
Moreover, hPSCs maintain expression of pluripotency markers, SSEA4,
OCT4, SOX2 and TRA-1-60 (Fig. 4C) after single-cell cloning and ex-
pansion processes in E8- or Stem-Flex culture medium. Final edited
Fig. 1. TrypLE-Select supports faster recovery of hPSCs growth following single-cell dissociation. (A) Comparison of diﬀerent hPSC passaging reagents for single-cell
dissociation. hPSCs dissociated with TrypLE-Select showed the best recovery from single-cell dissociation in (B) cell number and in (C) the number and size of hPSC
colonies (crystal violet staining) without addition of ROCKi (n=3). (D) Improved cell survival and growth was observed in E8-Flex: Matrigel supplemented with
ROCK inhibitor (Y-27632 or RevitaCell), but not SMC4 after single-cell passaging (n=3). Error bars denote the mean ± SEM. (*) p < 0.05, (**) p < 0.01. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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clones were routinely subjected to spontaneous diﬀerentiation by em-
bryoid body formation and subsequently plating on Matrigel with
serum-containing medium. After 4 weeks, hPSCs showed successful
diﬀerentiation into all three germ layers as assessed by immuno-
ﬂuorescence staining for speciﬁc markers for three somatic lineages
(Fig. 4D). Taken together, the robustness of this single-cell cloning
method can support screening, hPSC maintenance and expansion fol-
lowing genome-engineering processes.
4. Discussion
The recent development of site-speciﬁc nucleases and speciﬁcally
CRISPR-Cas9 to provide precise genome manipulation in hPSCs has
created new opportunities for studying human genetics and diseases.
However, genome editing in hPSCs remains diﬃcult because of their
intrinsically poor capacity to grow in single or very low cell densities.
While several deﬁned matrices and additives have been shown to
improve hPSCs single-cell survival and expansion (Emre et al., 2010;
Pijuan-Galito et al., 2016; Rodin et al., 2014; Valamehr et al., 2012;
Watanabe et al., 2007), none of the currently available methods fulﬁll
the need for a simple, robust, and cost-eﬃcient method for single-cell
expansion and cloning. In addition, traditional clonal isolation of edited
hPSCs involves limiting dilution and manual picking processes, which
often leads to mosaicism and are ineﬃcient and labor intensive (Li
et al., 2016; Yumlu et al., 2017). Therefore, a standardized method for
high-throughput hPSC clonal expansion following genome engineering
is needed.
While several studies have successfully demonstrated a workﬂow
for genome editing using hPSCs, these protocols rely heavily on FACS
enrichment, drug selection and manual colony picking (Byrne et al.,
2014; Santos et al., 2016; Yumlu et al., 2017). Additionally, some im-
provements for single-cell cloning have been reported, but with only
modest improvements in eﬃciency (between 5 and 20%) (Pijuan-Galito
et al., 2016; Valamehr et al., 2012). Here, we present a simple and
Fig. 2. RevitaCell and Geltrex/VN support cell survival after single cell sorting. (A) RevitaCell-supplemented medium (E8-Flex) exhibited increased single cell
cloning eﬃciency on surface coated with Matrigel compared to traditional ROCKi controls (n=3). (B) Comparison of diﬀerent coating matrices for hPSC culture. (C)
Single-Cell cloning eﬃciencies of diﬀerent hPSC lines on diﬀerent coating matrices (n= 3). (D) Diﬀerent culture conditions (cold, ﬁbronectin and conditioned
medium) did not improve single cell cloning eﬃciency, low oxygen tension (2.5%) decreased single clonal recovery relative to controls (n= 3). Error bars denote the
mean ± SEM. Scale bar, 100 μm. (*) p < 0.05, (**) p < 0.01.
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robust protocol to enhance hPSC single-cell survival and cloning with
eﬃciencies as high as 60% that also yields genomically stable hPSC
clones.
We evaluated diﬀerent passaging reagents, cell matrices, additives
and media to develop a robust protocol for selection and feeder free
single-cell cloning following genome editing. We found that 0.75×
TrypLE-S showed the best recovery rate for hPSCs following single cell
dissociation, consistent to previous ﬁndings (Nishishita et al., 2015).
Prior reports demonstrate that TrypLE-S is gentler on the cell surface
(Ellerstrom et al., 2007). Moreover, ROCK inhibitors, Y-27632 and
RevitaCell showed signiﬁcant improvement on single-cell survival. In
contrast, the SMC4 inhibitor cocktail did not improve single-cell sur-
vival, revealing ROCK inhibition is beneﬁcial for single-cell survival.
To establish a robust platform for single-cell cloning, we ﬂow-sorted
hPSCs as single cells into Matrigel-coated plates. While both Y-27632
and RevitaCell supported single-cell survival when plating pools of
single-cell clones, single-cell derived clones were only observed in
medium supplemented with RevitaCell. Additionally, we found that the
coating matrix used also inﬂuenced the clonal eﬃciency. This is the ﬁrst
time that hPSCs have been shown to have diﬀerent responses to the cell
matrices for single-cell cloning. Surprisingly, the most commonly used
matrix, Matrigel, showed the worst performance on single-cell cloning.
In contrast, Geltrex, VN and Laminin-521 demonstrated much more
consistent and higher cloning eﬃciencies.
While many hPSC culture systems have been shown to support
single-cell culture, expansion and maintenance of pluripotency, stan-
dard culture system may perform diﬀerently during single-cell cloning.
The reported clonal eﬃciencies for each medium are E8-Flex:< 5%;
Stem-Flex: 20 to 25% (SCIENTIFIC, 2017); mTeSR1 and TeSR-E8:
~20% (TECHNOLOGIES, 2017); DEF-CS: 25 to 30% (TakaRa, 2017). In
this study, we ﬁrst established the single-cell cloning workﬂow based
on E8-Flex culture system, and then applied it to diﬀerent culture sys-
tems with minor modiﬁcations to ﬁt the workﬂow. E8-Flex and Stem-
Flex showed overall higher cloning eﬃciency compared to other sys-
tems with Stem-Flex out-performing even E8-Flex in more diﬃcult
hPSC lines. While similar results were observed in Stem-Flex in re-
sponse to single cell dissociation (Fig. S2B vs. Fig. 1B), Stem-Flex
showed improved cell survival in SMC4 compared to E8-Flex (Fig. S2C
Fig. 3. E8-Flex and Stem-Flex demonstrate robust clonal expansion following single-cell sorting workﬂow. (A) A schematic workﬂow of single-cell sorting meth-
odologies for high eﬃcient single cell clonal expansion. (!) Fresh DEF-CS medium was prepared with additives (GF-1, GF-2 and GF-3) on the day of intended use. (*)
Pretreatment is not required for the use of CloneR. (B) Unbiased comparison of diﬀerent commercial hPSC culture systems for single-cell cloning eﬃciency (n=3).
(C) Stem-Flex shows consistently higher clonal eﬃciency in diﬃcult iPSCs (n=3). Error bars denote the mean ± SEM. Scale bar, 50 μm. (*) p < 0.05, (**)
p < 0.01.
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vs. Fig. 1D). More importantly, overall clonal eﬃciency was higher
following our workﬂow (E8-Flex: 30 to 50%; Stem-Flex: 37 to 58%;
mTeSR1: 22 to 30%; TeSR-E8: 22 to 35% and DEF-CS: 20 to 45%),
regardless of the culture system. In contrast to the typical hPSC mor-
phology, cells in DEF-CS culture medium showed less packed, but much
more scattered monolayer morphology (Fig. S2D). It should be noted
that CloneR supplement made a signiﬁcant improvement in single-cell
cloning following ﬂow sorting for both mTeSR1 and TeSR-E8 culture
systems as cloning eﬃciencies without CloneR in these two medium
was close to zero (data not shown). Additionally, we found more
Fig. 4. Genome edited clones maintains normal hPSC properties. (A) Summary of single clonal eﬃciency in diﬀerent genome engineering projects. (B) Representative
karyogram of a ﬁnal edited clone showing a normal karyotype. (C) Immunoﬂuorescence staining for pluripotency markers, SSEA4, OCT4, SOX2 and TRA-1-60. (D)
Immunoﬂuorescence staining for markers of three germ layers, endoderm with AFP (green), mesoderm with SMA (red) and ectoderm with TUJ1 (green), after
4 weeks of diﬀerentiation. Nuclei were counterstained with DAPI. Scale bar, 100 μm. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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consistent results following single-cell cloning by gradually reducing
CloneR concentrations as cells expanded rather than performing com-
plete media changes as per manufacturer's instructions (data not
shown). While the use of Laminin-521 as cellular substrata has shown
to improve single-cell growth of hPSCs under xeno-free and chemically
deﬁned conditions (Rodin et al., 2014), the current use of laminin for
high-throughput hPSC maintenance and expansion is limited due to the
high cost. In this study, we did not observe a signiﬁcant increase in
clonability across diﬀerent hPSCs using Laminin-521 (Fig. 2C, 3B and
S2E) compared with Geltrex or VN.
In this report, we summarize over 100 genome engineering projects
including parental cells, culture medium, modiﬁcation, type of donor,
and clonabiity following the single-cell cloning method (Table S1 and
S2). Interestingly, we found that type of modiﬁcation or donor was not
associated with single cell cloning eﬃciency (Fig. 4A), whereas some
particular patient iPSC lines show poor clonability. Additionally, most
knockout genes or deletion mutations have no signiﬁcant impact on
hPSC single cell cloning eﬃciency indicating that the defect on gene
function could be cell-type dependent. The presence of genetic varia-
tions in iPSCs could be the actual factor for adverse eﬀects on single cell
growth, moreover hampering the process of genome engineering.
Stressful single-cell dissociation under suboptimal conditions may lead
to selection of abnormal cells or to an in vitro-adapted cell line (Draper
et al., 2004; Imreh et al., 2006; Mitalipova et al., 2005). Interestingly,
there doesn't appear to be a correlation between reprogramming
method and clonability. Moreover, passage number is unlikely to aﬀect
clonability as we try to maintain hPSCs at low passage numbers and it
in general takes< 8 passages post nucleofection to identify a single cell
derived clone. While the causes for genetic changes of hPSCs are poorly
understood, we have not observed any karyotypic abnormalities post
single-cell enzymatic dissociation in any of the 41 hPSC genome editing
projects and total 92 modiﬁed clones that have been karyotyped.
Single-cell propagation and characterization of randomly selected
edited clones further support that this workﬂow is reliable and robust.
5. Conclusions
We have successfully leveraged diﬀerent culture methods to develop
a simple workﬂow that oﬀers a reliable and cost-eﬃcient solution to the
current need for hPSC single-cell cloning. This method can be combined
with the CRISPR-Cas9 technology to scarlessly generate engineered
hPSCs and further facilitate stem cell research.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2018.08.003.
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